Announcements Trials
Browse Landscape

Phase

Phase 4 1

Status

Completed 2Not yet recruiting 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Other hematologic neoplasm 1Classical hematology 1

Conditions

Neutropenia 1Neoplasms 1Hematologic Neoplasms 1Febrile Neutropenia 1

Interventions

fludarabine 3Cyclophosphamide 3Busulfan 2venetoclax 1trametinib 1luspatercept 1gilteritinib 1dabrafenib 1Whole-Body Irradiation 1Vancomycin 1Thiotepa 1Teicoplanin 1Tacrolimus 1Stem Cell Transplantation 1Rituximab 1Radiosurgery 1Ofloxacin 1NF protocol 1Mycophenolic Acid 1Metronidazole 1Meropenem 1Kidney Transplantation 1Granulocyte Colony-Stimulating Factor 1Genetic Testing 1Cytarabine 1Complementary Therapies 1Ciprofloxacin 1Ceftazidime 1Cefepime 1Blood Specimen Collection 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Not yet recruiting × Hematologic Neoplasms × Meropenem × Clear all
NCT07590648 2026-05-15

E-STOP2

Hospital Universitari Vall d'Hebron Research Institute

Phase 4 Not yet recruiting
136 enrolled
Classical hematologyOther hematologic neoplasm

Neoplasms, Neutropenia, Hematologic Neoplasms, Febrile Neutropenia

Data powered by HemOnc (CC BY 4.0) Colophon âš¡